Financial PerformanceKRMD delivered a strong quarter as it beat on revenue and margin expectations, seeing material outperformance in its OUS markets even taking distributor stocking into account.
Growth OpportunitiesKRMD raised its revenue guidance reflecting growth of now 15-17%, underpinned by SCIg market growth, global share gains, NRE revenue from new expected collaborations, flow controller line extension, and Japan market entry.
International ExpansionKRMD sees upside potential from OUS expansion into current and new markets as it works to increase its market share internationally.
Product InnovationThe new product initiative is focused on an easier-to-use and more comfortable pump and disposable infusion set.